📰 Genentech News
Page 103 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
September 7, 2023
By revealing how tumors interact with immune cells, Noetik aims to identify new targets for new cancer drugs. The startup and its artificial intelligence-driven platform are supported by $14 million in seed financing.
September 7, 2023
Crovalimab achieved disease control and non-inferiority compared to eculizumab, which is the current standard-of-care for individuals with paroxysmal nocturnal hemoglobinuria.
September 7, 2023
New biomarker tests identified NASH and related conditions at least as well as common lab tests, paving the way for blood-based alternatives to liver biopsy for clinical care and therapeutic trials.
September 7, 2023
As compared to conventional, stand-alone clinical trials in advanced non-small cell lung cancer (NSCLC), the biomarker-driven Lung Cancer Master Protocol (Lung-MAP) has enrolled higher percentages of patients who are older, patients who are from rural or socioeconomically deprived areas, and patients who have Medicaid or no insurance.
September 6, 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sep 6, 2023--
September 6, 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sep 6, 2023--
September 6, 2023
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sep 6, 2023--
September 6, 2023
Biogen Inc. said Wednesday it has appointed Dr. Jane Grogan as head of research, effective Oct. 2. Grogan was most recently chief scientific officer at...
September 6, 2023
LOS ALTOS, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today
September 6, 2023
Appointment adds decades of drug development experience from a seasoned executive...